These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10369861)

  • 1. High level expression of expanded full-length ataxin-3 in vitro causes cell death and formation of intranuclear inclusions in neuronal cells.
    Evert BO; Wüllner U; Schulz JB; Weller M; Groscurth P; Trottier Y; Brice A; Klockgether T
    Hum Mol Genet; 1999 Jul; 8(7):1169-76. PubMed ID: 10369861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains.
    Evert BO; Vogt IR; Kindermann C; Ozimek L; de Vos RA; Brunt ER; Schmitt I; Klockgether T; Wüllner U
    J Neurosci; 2001 Aug; 21(15):5389-96. PubMed ID: 11466410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias--triple-labeling immunofluorescence study.
    Uchihara T; Fujigasaki H; Koyano S; Nakamura A; Yagishita S; Iwabuchi K
    Acta Neuropathol; 2001 Aug; 102(2):149-52. PubMed ID: 11563629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
    Chai Y; Koppenhafer SL; Shoesmith SJ; Perez MK; Paulson HL
    Hum Mol Genet; 1999 Apr; 8(4):673-82. PubMed ID: 10072437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence.
    Bichelmeier U; Schmidt T; Hübener J; Boy J; Rüttiger L; Häbig K; Poths S; Bonin M; Knipper M; Schmidt WJ; Wilbertz J; Wolburg H; Laccone F; Riess O
    J Neurosci; 2007 Jul; 27(28):7418-28. PubMed ID: 17626202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 activation mediates polyglutamine-expanded ataxin-3 upregulation of Bax expression in cerebellar and pontine nuclei neurons.
    Chou AH; Lin AC; Hong KY; Hu SH; Chen YL; Chen JY; Wang HL
    Neurochem Int; 2011 Feb; 58(2):145-52. PubMed ID: 21092747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3.
    Haacke A; Broadley SA; Boteva R; Tzvetkov N; Hartl FU; Breuer P
    Hum Mol Genet; 2006 Feb; 15(4):555-68. PubMed ID: 16407371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potassium channel dysfunction and depolarized resting membrane potential in a cell model of SCA3.
    Jeub M; Herbst M; Spauschus A; Fleischer H; Klockgether T; Wuellner U; Evert BO
    Exp Neurol; 2006 Sep; 201(1):182-92. PubMed ID: 16765348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies.
    Kumada S; Uchihara T; Hayashi M; Nakamura A; Kikuchi E; Mizutani T; Oda M
    J Neuropathol Exp Neurol; 2002 Nov; 61(11):984-91. PubMed ID: 12430715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinocerebellar ataxia type 3 (SCA3): thalamic neurodegeneration occurs independently from thalamic ataxin-3 immunopositive neuronal intranuclear inclusions.
    Rüb U; de Vos RA; Brunt ER; Sebestény T; Schöls L; Auburger G; Bohl J; Ghebremedhin E; Gierga K; Seidel K; den Dunnen W; Heinsen H; Paulson H; Deller T
    Brain Pathol; 2006 Jul; 16(3):218-27. PubMed ID: 16911479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains.
    Fujigasaki H; Uchihara T; Koyano S; Iwabuchi K; Yagishita S; Makifuchi T; Nakamura A; Ishida K; Toru S; Hirai S; Ishikawa K; Tanabe T; Mizusawa H
    Exp Neurol; 2000 Oct; 165(2):248-56. PubMed ID: 10993685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Full-length expanded ataxin-3 enhances mitochondrial-mediated cell death and decreases Bcl-2 expression in human neuroblastoma cells.
    Tsai HF; Tsai HJ; Hsieh M
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1274-82. PubMed ID: 15504352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ataxin 1 and ataxin 3 in neuronal intranuclear inclusion disease.
    Lieberman AP; Trojanowski JQ; Leonard DG; Chen KL; Barnett JL; Leverenz JB; Bird TD; Robitaille Y; Malandrini A; Fischbeck KH
    Ann Neurol; 1999 Aug; 46(2):271-3. PubMed ID: 10443897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of the polyQ repeat in ataxin-2 alters its Golgi localization, disrupts the Golgi complex and causes cell death.
    Huynh DP; Yang HT; Vakharia H; Nguyen D; Pulst SM
    Hum Mol Genet; 2003 Jul; 12(13):1485-96. PubMed ID: 12812977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxin-3 with an altered conformation that exposes the polyglutamine domain is associated with the nuclear matrix.
    Perez MK; Paulson HL; Pittman RN
    Hum Mol Genet; 1999 Dec; 8(13):2377-85. PubMed ID: 10556285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
    Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
    Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients.
    Schmidt T; Landwehrmeyer GB; Schmitt I; Trottier Y; Auburger G; Laccone F; Klockgether T; Völpel M; Epplen JT; Schöls L; Riess O
    Brain Pathol; 1998 Oct; 8(4):669-79. PubMed ID: 9804376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse.
    Chou AH; Chen YL; Chiu CC; Yuan SJ; Weng YH; Yeh TH; Lin YL; Fang JM; Wang HL
    Neuropharmacology; 2015 Dec; 99():308-17. PubMed ID: 26254860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease.
    Takahashi J; Tanaka J; Arai K; Funata N; Hattori T; Fukuda T; Fujigasaki H; Uchihara T
    J Neuropathol Exp Neurol; 2001 Apr; 60(4):369-76. PubMed ID: 11305872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarities between spinocerebellar ataxia type 7 (SCA7) cell models and human brain: proteins recruited in inclusions and activation of caspase-3.
    Zander C; Takahashi J; El Hachimi KH; Fujigasaki H; Albanese V; Lebre AS; Stevanin G; Duyckaerts C; Brice A
    Hum Mol Genet; 2001 Oct; 10(22):2569-79. PubMed ID: 11709544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.